Konrad Zieliński, who lost his voice to cancer, created Uhura Bionics to develop wearable voice devices that enable natural-sounding speech for people without larynges, offering an innovative alternative to robotic, flat-sounding aids.
- Non-invasive devices bring emotional voice expression to laryngectomees
- Uhura’s Whitney model aims to be as common as glasses for eyesight
- Plans underway for medical classification and insurance reimbursement
What happened
Konrad Zieliński lost his voice to cancer years ago and experienced firsthand the limitations of traditional voice restoration methods, which often include robotic-sounding handheld devices or surgically implanted prostheses requiring ongoing maintenance. Motivated by his experience and his PhD research on bionic systems for voice loss, he founded Uhura Bionics in 2023 to create non-invasive voice devices.
Uhura Bionics currently offers two wearable voice devices: a basic model and a high-end version called Whitney, which Zieliński envisions will help users speak with emotion—laugh, shout, and sing—providing a more natural communication experience. The company has been selected as part of TechCrunch Disrupt 2026 Battlefield 200, showcasing its innovation on a prominent startup stage.
Why it matters
The common aids for people who have lost their larynx often provide speech that is flat and lacks emotional depth, which can impact social interaction and quality of life. Uhura Bionics addresses this gap by adding an emotional layer, making speech feel more human and expressive. This innovation could significantly improve daily communication for laryngectomees.
By aiming for Class I medical device status in Europe and the US, Uhura hopes to make these devices eligible for partial insurance reimbursement, increasing accessibility. The market for devices serving laryngectomees is estimated at $2 billion, with growth potential by also catering to people with other speech disorders.
What to watch next
Uhura Bionics plans to expand its voice options to include higher-pitched voices targeted for women and introduce personalization features so that users can have unique voice signatures rather than sounding alike. These advancements will be critical to broadening the product’s appeal and usability.
Zieliński will demonstrate the Whitney device not only at TechCrunch Disrupt but also at San Francisco Tech Week in October, where he will showcase the technology by singing onstage. Market competition includes companies like Atos Medical and startups such as Laronix, making ongoing innovation and differentiation essential for Uhura Bionics’ success.